WO2023079365 - SYSTEMS AND METHODS FOR TREATING CHRONIC SINUSITIS
National phase entry:
Publication Number
WO/2023/079365
Publication Date
11.05.2023
International Application No.
PCT/IB2022/000662
International Filing Date
03.11.2022
Title **
[English]
SYSTEMS AND METHODS FOR TREATING CHRONIC SINUSITIS
[French]
SYSTÈMES ET MÉTHODES DE TRAITEMENT DE LA SINUSITE CHRONIQUE
Applicants **
NEURENT MEDICAL LIMITED
No. 1 Oran Point
Main Street
Oranmore, Galway, IE
Inventors
TOWNLEY, David
Latoon North, Newmarket-on-Fergus
County Clare, IE
Priority Data
63/275,701
04.11.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1139 | |
| EPO | Filing, Examination | 4598 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 9613 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention generally relates to systems and methods for targeting of specific tissue(s) of interest within a sino-nasal region of a patient, specifically sinus regions (i.e., ostia and sinus cavities), for the treatment of chronic sinusitis conditions.[French]
L'invention concerne de manière générale des systèmes et des méthodes de ciblage d'un ou de plusieurs tissus d'intérêt spécifiques dans une région sino-nasale d'un patient, spécifiquement des régions de sinus (c'est-à-dire, ostia et sinus), pour le traitement de sinusites chroniques.